| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Lineage Cell Therapeutics, Inc. (LCTX) has 8 insiders with recent SEC Form 4 filings, including 12 buys and 2 sells. LCTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 255.5K | $327.1K | - | |
| 10% | 75.0K | $96.0K | - | |
| Dir | 75.0K | $96.0K | - | |
| Dir | 75.0K | $96.0K | - | |
| Dir | 75.0K | $96.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 15, 2017 | Broadwood Partners, L.P.60 | Director, 10% Owner | Buy | 2,222,222 | $2.70 | $5,999,999.40 | +4.3% | |
| Jun 21, 2016 | Broadwood Partners LP60 | Director, 10% Owner | Buy | 2,732,636 | $2.39 | $6,531,000.04 | +5.8% | |
| Jan 20, 2016 | Kingsley Alfred D | See Remarks | Sell | 300,000 | $2.35 | $705,000.00 | -5.1% | |
| Jan 20, 2016 | Broadwood Partners LP60 | Director, 10% Owner | Buy | 300,000 | $2.35 | $705,000.00 | +0.7% | |
| Nov 6, 2015 | Kingsley Alfred D | See Remarks | Sell | 100,000 | $3.83 | $383,000.00 | -1.7% | |
| Nov 6, 2015 | Russell Angus C. | Director | Buy | 50,000 | $3.83 | $191,500.00 | +285.7% | |
| Nov 6, 2015 | Farrell Stephen C | Director | Buy | 50,000 | $3.83 | $191,500.00 | +105.4% | |
| Aug 26, 2015 | Andrews Deborah J | Director | Buy | 2,000 | $2.82 | $5,640.00 | New | |
| Aug 18, 2015 | Cartt Stephen Lahue | Director | Buy | 75,000 | $2.80 | $210,066.52 | +23.7% |